[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. [PDF]
Wang XY, Sun HM, Gao YH.
europepmc +1 more source
[Dual role and therapeutic potential of TREM2 in atherosclerosis]. [PDF]
Liao L, Zeng C, Tang P, Chen P, Hu X.
europepmc +1 more source
[<i>Jianpi Zishen</i> Formula improves renal damage in mice with systemic lupus erythematosus by inhibiting p53-MDM2 signaling axis-mediated ferroptosis]. [PDF]
Li Y, Huang C, Pang L, Zhu Z, Li M.
europepmc +1 more source
[Precise clinical classification of metabolic associated fatty liver disease]. [PDF]
Su WR, Ding JJ, Pan Q, Chai J.
europepmc +1 more source
[Advances in immunomodulatory strategies for meniscal regeneration]. [PDF]
Li J +7 more
europepmc +1 more source
[Research progress on mitochondria-lipid droplet coupling and its regulation of lipid metabolism and obesity]. [PDF]
Zheng W, Long Y, Yang L.
europepmc +1 more source
[Effect of inferior alveolar nerve transection on mandibular condyles in rats and the repair effect of calcitonin gene-related peptide]. [PDF]
Zhang M, Cheng K, Li J, Liu Z, Jiang T.
europepmc +1 more source
[Single<b>-</b>cell RNA sequencing reveals the driving mechanism of CXCL9<b>꞉</b>SPP1 polarization in the progression of non-alcoholic fatty liver disease]. [PDF]
Lu Y, Ni W, Chen R, Wang W.
europepmc +1 more source

